Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Coupes

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Transplantation|June 9, 2001
Strategies for meaningful measurement of circulating levels of transforming growth factor beta1 in clinical samplesP E Brenchley, S Williams, B Coupes, et al.
Clinical Nephrology|July 23, 2003
Clinical correlates of serial urinary membrane attack complex estimates in patients with idiopathic membranous nephropathyD C Cattran, R Wald, P E C Brenchley, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|January 1, 1992
Clinical aspects of C3dg and C5b-9 in human membranous nephropathyB Coupes, P E Brenchley, C D Short, et al.
Annals of the Rheumatic Diseases|November 1, 1994
Plasma TGF beta in systemic sclerosis: a cross-sectional studyN Snowden, B Coupes, A Herrick, et al.
The New England Journal of Medicine|September 1, 1983
Gm allotypes in membranous nephropathyP Brenchley, J Feehally, P Doré, et al.
Kidney International|April 1, 1992
Urinary C3dg and C5b-9 indicate active immune disease in human membranous nephropathyP E Brenchley, B Coupes, C D Short, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|May 13, 2014
Epstein-Barr virus infection in adult renal transplant recipientsM Morton, B Coupes, S A Roberts, et al.
Kidney International|December 1, 1995
Urinary C5b-9 excretion and clinical course in idiopathic human membranous nephropathyS P Kon, B Coupes, C D Short, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Transplantation|June 9, 2001
Strategies for meaningful measurement of circulating levels of transforming growth factor beta1 in clinical samplesP E Brenchley, S Williams, B Coupes, et al.
Clinical Nephrology|July 23, 2003
Clinical correlates of serial urinary membrane attack complex estimates in patients with idiopathic membranous nephropathyD C Cattran, R Wald, P E C Brenchley, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|January 1, 1992
Clinical aspects of C3dg and C5b-9 in human membranous nephropathyB Coupes, P E Brenchley, C D Short, et al.
Annals of the Rheumatic Diseases|November 1, 1994
Plasma TGF beta in systemic sclerosis: a cross-sectional studyN Snowden, B Coupes, A Herrick, et al.
The New England Journal of Medicine|September 1, 1983
Gm allotypes in membranous nephropathyP Brenchley, J Feehally, P Doré, et al.
Kidney International|April 1, 1992
Urinary C3dg and C5b-9 indicate active immune disease in human membranous nephropathyP E Brenchley, B Coupes, C D Short, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|May 13, 2014
Epstein-Barr virus infection in adult renal transplant recipientsM Morton, B Coupes, S A Roberts, et al.
Kidney International|December 1, 1995
Urinary C5b-9 excretion and clinical course in idiopathic human membranous nephropathyS P Kon, B Coupes, C D Short, et al.
Pageof 1